Clinical trial

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Opening soon · Not applicable · 1 countries · Registry ID NCT07388537

Opening soonNot applicableObservational

What this study is about

Background: Diabetes and obesity are chronic diseases. They can affect blood flow and how the body processes nutrients, and complications over time can lead to early death. Diabetes can affect children as well as adults, but the disease seems to be more severe and to progress faster when it appears in younger people. Researchers want to understand more about how diabetes and obesity develop and change over time. Objective: To collect data and samples regularly from people with obesity and diabetes. Eligibility: People aged 8 to 65 years. They must be overweight or obese; or have high blood sugar; or have problems with how their body uses food for energy. Design: Participants will have additional procedures during routine care visits at the NIH clinic. Data collected for the study will include the following: Information from the participant s medical chart will be kept for research. Questionnaires will ask about participant s eating habits, feelings, sleep, and substance use. They will take 30 to 60 minutes. Care providers will address any issues revealed in these surveys. Blood, saliva, urine, and stool samples will be collected. Samples may be used for genetic tests. Data and samples will be kept for future research. Participants may remain in the study up to 30 years.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age8 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity, Diabetes, Metabolic Disorders

Full registry criteria

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Age 8 years to 65 years 2. Meet at least one of the following: a. Overweight/Obesity: i. For participants under 18 years of age: BMI \>= 85th percentile for age and sex ii. For participants \>= 18 years of age: BMI \>= 25 kg/m\^2 (\>=23 kg/m\^2 for self-reported Asian race/ethnicity) b. Suspected or evidence of hyperglycemia: i. Diagnosis of prediabetes or diabetes in medical history or by participant/guardian/Legally Authorized Representative (LAR) report, OR ii. Fasting blood glucose \>= 100 mg/dL in medical record, OR iii. Postprandial blood sugar \>= 140 mg/dL in medical record, OR iv. Hemoglobin A1c \>= 5.7% in medical record EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. History of significant medical illnesses that the investigators feel may interfere with potential evaluations, i.e. individuals who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on Clinical Center or NIDDK resources. 2. History of any medical, psychiatric, or social conditions which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the participant. 3. Inability or unwillingness of participant, parent/guardian, or LAR to provide informed consent.

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

To collect data and samples during clinical evaluation, treatment, and follow-up of participants for use in future studies.Up to 30 years

Samples including whole blood, saliva/buccal swabs, urine, and/or stool will be collected and stored for use in future studies to test our hypothesis that individuals with youth and adult early-onset diabetes and obesity will have high rates of metabolic complications and rapid disease progression compared to adults who develop diabetes later in their life. These samples will be collected during the participants' clinical care visits

Study locations

1 locations were listed when this page was built. The first 40 are shown.

National Institutes of Health Clinical Center🇺🇸 Bethesda, Maryland, United States
Noemi Malandrino, M.D.Contact
Lilian MabundoContact